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A B S T R A C T
Human papillomavirus (HPV) genotypes and
HPV DNA load were analysed in cervical smears
from 76 human immunodeficiency virus (HIV)-
positive and 54 HIV-negative women. The preval-
ence of genotypes was similar for all women, with
the exception of HPV62, which was over-repre-
sented in HIV-positive samples. HIV-positive
women showed a higher prevalence of multiple
genotypes that correlated neither with CD4+ T-cell
counts nor with cervical dysplasia. No significant
differences were observed in terms of total or
single-type HPV DNA load. The HPV DNA load
in both HIV-positive and HIV-negative women
was significantly higher in squamous intra-epi-
thelial lesions than in negative Pap smears.
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Human papillomavirus (HPV) is the most com-
mon sexually transmitted infectious organism
among females [1,2]. Genital strains of HPV are
usually characterised as ‘high-risk’ (HR) or ‘low-
risk’ (LR) types, depending on their prevalence in
cervical carcinoma [3]. Immunodeficiency associ-
ated with human immunodeficiency virus (HIV)
may enhance the risk of HPV infection, promote
reactivation of latent infection and favour HPV
persistence [4–6], resulting in an increased risk of
cervical dysplasia and progression to cancer. The
aim of the present study was to evaluate the
virological markers of HPV infection that could be
used to monitor HPV infection in HIV-positive
women, focusing on HPV types and type-specific
HPV DNA loads and their correlation with the
grade of cervical lesion.
During the studyperiod (March2003 toFebruary
2005), 214 HIV-positive women visited the outpa-
tient clinic of the National Institute for Infectious
Diseases Lazzaro Spallanzani, of whom 108 were
HPV-positive. Of the 108 HPV-positive women, 76
were enrolled in the study. The epidemiological
and immunological characteristics of the women
enrolled were similar to those of non-enrolled
women: mean age, 38.6 vs. 38.4 years, p 0.93;
history of intravenous drug use, 44.4% vs. 50.0%,
p 0.72; and mean number of CD4+ cells at time of
examination, 476.5 vs. 501.5 cells ⁄lL, p 0.71.
Fifty-four HIV-negative ⁄HPV-positive out-
patients were selected from amongwomen attend-
ing the Department of Gynaecological Sciences,
Perinatology and Puericulture of La Sapienza
University and Sant’ Andrea Hospital in Rome;
thesewerematched to theHIV-positivewomen for
cervical cytological results (Table 1). Although the
mean ages are apparently statistically different
(p <0.05), the two groups were matched by age in
5-year bands, since it was difficult to obtain
comparable data for both exact age and cytology.
All the women underwent routine gynaecological
monitoring, including Pap tests, and the collection
of cervical samples for HPV DNA detection.
Having given informed consent for inclusion in
the study, all participants underwent a serological
test to confirm their HIV status. A blood sample
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was taken fromHIV-positivewomenduring exam-
ination to determine their HIV viral loads and
CD4+ T-cell counts. All Pap smears were classified
as either negative, ASCUS (aspecific squamous
cells of undetermined significance), LSIL (low-
grade squamous intra-epithelial lesions), or HSIL
(high-grade squamous intra-epithelial lesions) [7].
DNA purified from cervical brushes with an
extraction kit (Qiagen, Hilden, Germany) was
genotyped by sequencing a 450-bp fragment
amplified from the L1 region of the HPV DNA
[8]. Sequence homology was determined using
the BLAST and Clustal W programs. In order to
detect multiple infections, HPV genotypes were
also determined using a reverse line-blot hybrid-
isation assay (Innogenetics, Gent, Belgium) [9].
The HPV DNA load was measured by means of
a quantitative real-time Taqman PCR fluorogenic
assay (Applied Biosystems, Warrington, UK)
using 20–50 ng of DNA, quantified with a Ribo-
green fluorogenic assay (Invitrogen, Carlsbad,
CA, USA); this represented 0.5–5% of the total
extracted DNA (i.e., viral and cellular DNA).
Specific primers and probes for HR types (HPV16,
18, 31, 33, 35, 45, 53, 55, 56, 58, 59, 66, 68 and 73)
and LR types (HPV6, 11, 42, 44, 54, 61, 62, 71, 72,
81, 83 and 84) were designed to anneal to the HPV
E6 region. Copy numbers were calculated using
an external standard (recombinant plasmid DNA
containing the cloned E6 gene), with a lower
sensitivity limit of £10 copies ⁄ng of input DNA.
The baseline characteristics of the HIV-positive
and HIV-negative women are summarised in
Table 1. The prevalence of HR and LR HPV types
did not differ significantly between HIV-positive
and HIV-negative women (62.5% HR, 37.5% LR
vs. 64.4% HR, 35.6% LR; p >0.05), but a differ-
ence seemed to exist in the frequency of multiple
infections (67.1% in HIV-positive women vs. 40%
in HIV-negative women; p < 0.01). HPV16 was
the most prevalent genotype in all women; the
only difference was HPV62, which was over-
represented in the HIV-positive group (seven
cases vs. one). The distribution of HPV types
according to Pap test results showed that HSIL
and LSIL were associated mainly with specific HR
types in both HIV-positive and HIV-negative
women (HSIL with HPV16, 18, 31, 33 and 66;
LSIL with HPV16, 18, 31, 33, 35, 53, 56, 58 and 59).
HR types were also prevalent in those women
classified as ASCUS (HPV16, 18, 31 and 33).
Quantitative analysis of HPV DNA revealed no
significant differences in either total or single-type
HPV DNA load between HIV-positive and HIV-
negativewomen.However,HR types (e.g., HPV16,
18, 31, 58 and 66) showed a tendency to reach a
cumulatively higher viral load (Table 2). Stratifi-
cation of HPV DNA loads according to Pap test
results showed that the HPV DNA load in both
study groups was significantly higher in women
with squamous intra-epithelial lesions (both HSIL
andLSIL) than inwomenwithnegative Pap smears
(Fig. 1). The HPV DNA load in HIV-negative
women with HSIL was significantly higher than
that in womenwith LSIL (p <0.05). A similar trend
was observed in HIV-positive patients, but the
differences did not reach statistical significance
(p 0.07). In HIV-positive women, a moderate
inverse correlation was observed between HPV
DNA load and CD4+ T-cell count (r = )0.30;
Table 1. Baseline characteristics of women participating in
the study
Characteristic HIV-positive HIV-negative p values
Age: median, years (range) 39 (21–58) 32 (18–63) <0.05
CD4+ T-cell ⁄ count: median (range) 426 (25–1184) NA
HIV RNA copies ⁄mL:
median (range)
269 (<50–220 622) NA
Number of sexual partners: median 6.3 3.4 <0.01
Prevalence of HPV genotypes (%)
HR 62.5 64.4 >0.05
LR 37.5 35.7 >0.05
Infection with multiple
genotypes
67.1 40.0 <0.01
Distribution of patients
according to Pap smear test results: n (%)
Negative 41 (54) 29 (54)
ASCUS 4 (5) 3 (5)
LSIL 23 (30) 18 (33)
HSIL 8 (11) 4 (7)
Total number of patients 76 54
NA, not applicable; HIV, human immunodeficiency virus; HPV, human papillo-
mavirus; HR, high-risk (HPV16, 18, 31, 33, 35, 45, 53, 55, 56, 58, 59, 66, 68 and 73);
LR, low-risk (HPV6, 11, 42, 44, 54, 61, 62, 71, 72, 81, 83 and 84); ASCUS, aspecific
squamous cells of undetermined significance; LSIL, low-grade squamous intra-
epithelial lesions; HSIL, high-grade squamous intra-epithelial lesions.
Table 2. Type-specific human papillomavirus (HPV)
DNA loads and genotypes
HPV DNA load
HR HPV genotypes LR HPV genotypes
16 18 31 53 58 66 6 11 61
Copies ⁄ng total DNA,
log median
3.8 4.2 4.1 3.3 4.4 5.2 2.9 2.8 2.4
CD4 cell count Pap smear
<200 200–400 400–700 >700 SIL Neg
Number of HPV types,
median
2.9 2.8 2.5 2.9 2.7 2.8
HIV, human immunodeficiency virus; HR, high-risk; LR, low-risk: SIL, squamous
intra-epithelial lesions.
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p <0.05); moreover, the median number of HPV
types in infection correlated with neither CD4+ T-
cell count nor with grade of cervical lesion
(Table 2). In conclusion, this study of the virologi-
cal markers of HPV infection in HIV-positive and
HIV-negative women showed: (i) that the circula-
tion of genotypes was similar in both groups, with
the notable exception of HPV62, which was over-
represented in HIV-infected women (given that
HPV62 is detected infrequently in healthy popula-
tions in Italy [10], this genotype may replicate at
undetectable levels in immunocompetent hosts,
with its replication being enhanced by HIV
co-infection); (ii) that type-specific HPV DNA
loads did not differ between HIV-positive and
HIV-negativewomen, and that HR types showed a
tendency towards a higher cumulative viral load
compared with LR types in both groups; (iii) that
HIV-positive women had a high prevalence of
multiple infections that didnot correlatewithCD4+
T-cells or with lesions, which suggests that these
may be related to a greater number of sexual
partners rather than the degree of immunodefi-
ciency; and (iv) that HPV DNA loads in HIV-
positive women had a moderate correlation with
the level of immunosuppression, suggesting that
HPV replication is somewhat increased in HIV
infection, as reported by Strickler et al. [11].
Thus, the distribution and prevalence of HPV
types, as well as HPV DNA load, were almost
equivalent in both HIV-positive and HIV-negative
women. Although the HIV-positive and HIV-neg-
ative women were not matched exactly by age, the
HPV DNA load showed a significant correlation
with the severity of cervical disease in both groups,
as has been reported previously [12–14]. Therefore,
the present data substantiate the importance
of HPV DNA load as a risk-factor for cervical
dysplasia, and possibly for cancer development.
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Fig. 1. Human papillomavirus (HPV) in (a) human immu-
nodeficiency virus (HIV)-positive women (n = 76) and (b)
HIV-negative women (n = 54) according to Pap smear test
results. HSIL, high-grade squamous intra-epithelial le-
sions; LSIL, low-grade squamous intra-epithelial lesions;
ASCUS, aspecific squamous cells of undetermined signi-
ficance; NEG, negative.
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A B S T R A C T
This study examined the association between
transforming growth factor (TGF)-b1 polymor-
phisms and brucellosis. The TGF-b1 genotypes at
codons 10 and 25 were determined by an amplifi-
cation refractory mutation system-PCR among 425
brucellosis patients and 213 healthy volunteers.
The frequencies of TGF-b1 codons 10 C and 25 G
were significantly higher among patients than
among controls, as was that of TGF-b1 codon
10 C ⁄C.Thehigh-producerhaplotype(CG ⁄TG)was
more frequent among patients than among con-
trols. The findings suggest that genetic polymorph-
ism in codons 10 and 25 of the TGF-b1 gene might
contribute to the development of brucellosis.
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Brucella spp. are Gram-negative, facultative, intra-
cellular bacteria that cause the chronic zoonotic
disease known as brucellosis. Genetic polymor-
phisms affecting the production levels of certain
cytokines may be important determinants of risk,
severity and ⁄ or protection for some infectious
diseases [1]. Two single nucleotide polymor-
phisms have been identified in the DNA sequence
encoding the signal sequence of the transforming
growth factor (TGF)-b1 cytokine, located at posi-
tions +869 and +915, that result, respectively, in
variations of codons 10 (Leu to Pro) or 25 (Arg to
Pro) [2]. Both single-base substitutions result in
different levels of TGF-b1 production, and three
different cytokine-producer types have been dis-
tinguished [3,4]. Although the immunogenetic
aspects of chronic intracellular infections have
been studied extensively, little is known about the
host’s genetic influence on human brucellosis.
The present case-control study was designed to
assess the association between single nucleotide
polymorphisms of T+869C and G+915C at exon 1
of the TGF-b1 gene and susceptibility to brucel-
losis, and to identify any haplotypes associated
with predisposition to brucellosis.
In total, 425 (206 male and 219 female) brucel-
losis patients referred to Sina Hospital, Hamadan
Province, Iran and 213 (184 male and 29 female)
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